POLY(CYANURIC CHLORIDE-CO-TERT-OCTYLAMINE-CO-1,6-BIS(2,2,6,6-TETRAMETHYL-4-PIPERIDYLAMINO)HEXANE)
General Information
Mainterm | POLY(CYANURIC CHLORIDE-CO-TERT-OCTYLAMINE-CO-1,6-BIS(2,2,6,6-TETRAMETHYL-4-PIPERIDYLAMINO)HEXANE) |
CAS Reg.No.(or other ID) | 70624-18-9 |
Regnum |
178.2010 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 93418 |
IUPAC Name | N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine;2,4,6-trichloro-1,3,5-triazine;2,4,4-trimethylpentan-2-amine |
InChI | InChI=1S/C24H50N4.C8H19N.C3Cl3N3/c1-21(2)15-19(16-22(3,4)27-21)25-13-11-9-10-12-14-26-20-17-23(5,6)28-24(7,8)18-20;1-7(2,3)6-8(4,5)9;4-1-7-2(5)9-3(6)8-1/h19-20,25-28H,9-18H2,1-8H3;6,9H2,1-5H3; |
InChI Key | ORECYURYFJYPKY-UHFFFAOYSA-N |
Canonical SMILES | CC1(CC(CC(N1)(C)C)NCCCCCCNC2CC(NC(C2)(C)C)(C)C)C.CC(C)(C)CC(C)(C)N.C1(=NC(=NC(=N1)Cl)Cl)Cl |
Molecular Formula | C35H69Cl3N8 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 708.343 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 11 |
Complexity | 562.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B / w A A G A A A A A A A A A A A A A A A A A A A A A A A s W L A A A A A A A A A B g A A A H A I Q A A A A D q j B A A Q D E A b I E A A g A A A A J A A A A A k A A I A B A I A I A A C A C A I A w A A E A A A I E A C A A A E Q g E A N A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 113.0 |
Monoisotopic Mass | 706.471 |
Exact Mass | 706.471 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 46 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 3 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.7409 |
Human Intestinal Absorption | HIA+ | 0.9594 |
Caco-2 Permeability | Caco2- | 0.5987 |
P-glycoprotein Substrate | Substrate | 0.7359 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6332 |
Inhibitor | 0.6840 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.5232 |
Distribution | ||
Subcellular localization | Lysosome | 0.8225 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8458 |
CYP450 2D6 Substrate | Non-substrate | 0.7384 |
CYP450 3A4 Substrate | Substrate | 0.5202 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6161 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8247 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5484 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7202 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7304 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8603 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8653 |
Inhibitor | 0.7654 | |
AMES Toxicity | Non AMES toxic | 0.6859 |
Carcinogens | Non-carcinogens | 0.9057 |
Fish Toxicity | High FHMT | 0.8262 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9957 |
Honey Bee Toxicity | Low HBT | 0.8213 |
Biodegradation | Not ready biodegradable | 0.9972 |
Acute Oral Toxicity | III | 0.6038 |
Carcinogenicity (Three-class) | Non-required | 0.4730 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.6212 | LogS |
Caco-2 Permeability | 0.5105 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.6864 | LD50, mol/kg |
Fish Toxicity | 1.6705 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.6242 | pIGC50, ug/L |
From admetSAR